在标准急性髓细胞白血病诱导化疗中加入依托泊苷并不能提高生存率。 - Suppr | 超能文献

Addition of etoposide to standard acute myeloid leukaemia induction chemotherapy does not improve survival.

作者信息

Jackson K, Mollee P, Morris K, Kennedy G

出版信息

Intern Med J. 2013 Aug;43(8):953-4. doi: 10.1111/imj.12218.

DOI:10.1111/imj.12218

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Addition of etoposide to standard acute myeloid leukaemia induction chemotherapy does not improve survival.在标准急性髓细胞白血病诱导化疗中加入依托泊苷并不能提高生存率。

Intern Med J. 2013 Aug;43(8):953-4. doi: 10.1111/imj.12218.

2

7 + 3 idarubicin is still an effective induction therapy in acute myeloid leukaemia.7 + 3 伊达比星仍是急性髓系白血病有效的诱导治疗方案。

Intern Med J. 2014 Aug;44(8):823-4. doi: 10.1111/imj.12492.

3

Author reply: To PMID 22757980.作者回复：致PMID 22757980。

Intern Med J. 2014 Aug;44(8):825. doi: 10.1111/imj.12506.

4

High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia.高剂量阿糖胞苷（24 g/m2）联合伊达比星（HiDAC-3）治疗成人急性髓系白血病，第一周期反应率高，胃肠道毒性有限。

Intern Med J. 2013 Mar;43(3):294-7. doi: 10.1111/j.1445-5994.2012.02868.x.

5

Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.氟达拉滨与阿糖胞苷联合用于诱导成年急性髓系白血病患者治疗

Acta Haematol. 2017;137(1):15-16. doi: 10.1159/000449277. Epub 2016 Nov 3.

6

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.高剂量阿糖胞苷诱导治疗可改善年龄<46 岁成人急性髓系白血病患者的预后：EORTC-GIMEMA AML-12 试验结果。

J Clin Oncol. 2014 Jan 20;32(3):219-28. doi: 10.1200/JCO.2013.51.8571. Epub 2013 Dec 2.

7

Induction chemotherapy in acute myeloid leukaemia: origins and emerging directions.急性髓系白血病的诱导化疗：起源与新方向。

Curr Opin Hematol. 2018 Mar;25(2):67-74. doi: 10.1097/MOH.0000000000000407.

8

Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study.在未接受移植的急性髓系白血病患者中，强化基于柔红霉素的诱导化疗改善生存的潜力：一项多中心回顾性研究。

Leuk Res. 2015 Aug;39(8):812-7. doi: 10.1016/j.leukres.2015.04.015. Epub 2015 May 2.

9

New induction and postinduction strategies in acute myeloid leukemia.急性髓系白血病的新诱导和诱导后策略。

Curr Opin Hematol. 2012 Mar;19(2):76-81. doi: 10.1097/MOH.0b013e3283500a92.

10

Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.≥70岁新诊断急性髓系白血病患者强化诱导化疗与基于去甲基化药物方案的对比

Hematol Oncol. 2018 Apr;36(2):495-497. doi: 10.1002/hon.2456. Epub 2017 Jun 30.